Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quest Diagnostics Inc DGX

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer... see more

Recent & Breaking News (NYSE:DGX)

Quest Diagnostics Elects Luis A. Diaz, Jr., M.D. to its Board, Expanding the Number of Directors to 10

PR Newswire May 17, 2023

Quest Diagnostics Declares Quarterly Cash Dividend

PR Newswire May 16, 2023

Quest Diagnostics Extends Alzheimer's Disease Portfolio with New AI-Powered Test Service from uMETHOD Health

PR Newswire May 4, 2023

Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

PR Newswire April 27, 2023

Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio

PR Newswire April 27, 2023

Quest Diagnostics and NewYork-Presbyterian Complete Laboratory Services Acquisition

PR Newswire April 17, 2023

Quest Diagnostics to Release First Quarter 2023 Financial Results on April 27, 2023

PR Newswire April 4, 2023

Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States

PR Newswire March 22, 2023

First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com

PR Newswire March 21, 2023

Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine

PR Newswire March 20, 2023

Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day

PR Newswire March 16, 2023

Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board

PR Newswire March 3, 2023

Quest Diagnostics Teams Up with Tower Health to Deliver High-Value, Innovative Laboratory Services

PR Newswire February 16, 2023

Quest Diagnostics and NewYork-Presbyterian Agree to Laboratory Services Transaction

PR Newswire February 14, 2023

Quest Diagnostics to Host Investor Day on March 16, 2023

PR Newswire February 13, 2023

QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023

PR Newswire February 2, 2023

Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization

PR Newswire February 2, 2023

FORTUNE Magazine Names Quest Diagnostics one of 2023 "World's Most Admired Companies" for Ninth Consecutive Year

PR Newswire February 1, 2023

More Americans Know Their Horoscope Sign Than Their Blood Type, Survey Reveals

PR Newswire January 23, 2023

Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023

PR Newswire January 20, 2023